Riskpilot← Back to searchSign inGet full accessEUROEYES ApS
APSActiveCVR 20406135Per Henrik Lings Allé 4, 3.Medical specialists activities · NACE 8622Est. 199735 employeeswww.euroeyes.dk
Revenue 2024
DKK 39,2M
-25% vs 2023
EBITDA margin
32.8%
-48% vs 2023
Equity ratio
86.8%
Financial strength
Net profit 2024
DKK 6,3M
-60% vs 2023
| Revenue | DKK 39,2M | -25% |
| EBITDA | DKK 12,9M | -48% |
| Net profit | DKK 6,3M | -60% |
| Total assets | DKK 66,4M | +4% |
| Equity | DKK 57,6M | +12% |
| Employees | 35 | — |
Legal name
EUROEYES ApS
CVR number
20406135
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
23. september 1997
Share capital
DKK 135.000
Employees
35 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller den samlede bestyrelse.
Company purpose
Selskabets formål er at drive øjenklinikvirksomhed i bredeste forstand herunder speciallæge-, konsulent- og forskningsvirksomhed samt foretage operationer som led i denne virksomhed.
Address
Per Henrik Lings Allé 4, 3.
Phone
+4539631525
Email
jba@euroeyes.dk
Website
www.euroeyes.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 28.925 | 39.064 | 33.735 | 52.175 | 39.197 |
| Staff expenses | -18.272 | -18.535 | -20.133 | -27.509 | -26.327 |
| EBITDA | 10.653 | 20.529 | 13.601 | 24.665 | 12.870 |
| Depreciation & amort. | -728 | -566 | -1.915 | -4.298 | -5.173 |
| EBIT | 9.925 | 19.962 | 11.686 | 20.368 | 7.697 |
| Net financials | -196 | -240 | -210 | 20 | 375 |
| Profit before tax | 9.729 | 19.723 | 11.476 | 20.387 | 8.072 |
| Tax | 2.156 | 4.342 | 2.575 | 4.418 | 1.751 |
| Net profit | 7.573 | 15.380 | 8.901 | 15.970 | 6.321 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 30.257 | 38.797 | 51.454 | 63.585 | 66.376 |
| Equity | 11.033 | 26.414 | 35.314 | 51.284 | 57.605 |
| Long-term debt | 1.355 | 0 | 0 | 0 | 0 |
| Short-term debt | 17.869 | 12.287 | 14.777 | 11.659 | 7.899 |
| Total debt | 19.224 | 12.287 | 14.777 | 11.659 | 7.899 |
EBITDA margin
32.8%
This company
15.8%
Market median
+108% vs market
20202024
Equity ratio
86.8%
This company
38.2%
Market median
+127% vs market
20202024
Return on equity
11.0%
This company
18.4%
Market median
+40% vs market
20202024
Net profit margin
16.1%
This company
8.1%
Market median
+99% vs market
20202024
Asset turnover
0.59×
This company
1.12×
Market median
-47% vs market
20202024
Debt / equity
0.15×
This company
0.62×
Market median
+76% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LJ Management | Management | 1997 |
| Former (1) | ||
JA | Audit | 1997 – 1999 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 1997 | |
| Former (1) | ||
| Chairman | 1997 – 2011 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2009 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EUROEYES ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Jannik Boberg-Ans | Management | 0 companies |
| JWS-REVISION ApS 1984 | Audit | 0 companies |
| Jørn Slot Jørgensen | Board of Directors | 0 companies |
| Ulrik Iversen | Chairman | 0 companies |